title: Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol.
abstract: The purpose of this study was to evaluate the effect of topical timolol 0.5%, betaxolol 0.5% and carteolol 2% on the blood flow velocity of the central retinal artery (CRA), the posterior ciliary artery (PCA) and the ophthalmic artery (OA) in patients with ocular hypertension. A group of 14 patients with ocular hypertension and a group of 11 normals were studied. The color Doppler was used to measure the peak systolic flow velocity (PSFV) and the end diastolic flow velocity (EDFV) of the CRA, the PCA and the OA in the normals and in the patients. The normals were under no treatment, while the patients were studied before and after treatment with topical timolol 0.5%, betaxolol 0.5% and carteolol 2%. In the systolic phase, there was a significant increase in the flow velocity of the CRA with all three drugs. In the diastolic phase of the CRA, the increase was significant for timolol 0.5% and carteolol 2% but not for betaxolol 0.5%. The flow velocity of the PCA and OA remained unchanged. In this study of 14 patients with ocular hypertension, topical timolol 0.5%, betaxolol 0.5% and carteolol 2% led to a significant increase in the flow velocity of the CRA without creating a steal or decrease in the flow velocity of the PCA.
authors.affiliation: Angiology and Vascular Surgery Center, San Valentino, Pescara, Italy. r.steigerwalt@libero.it
authors.forename: R D
authors.initials: RD
authors.lastname: Steigerwalt
authors.forename: G
authors.initials: G
authors.lastname: Laurora
authors.forename: G V
authors.initials: GV
authors.lastname: Belcaro
authors.forename: M R
authors.initials: MR
authors.lastname: Cesarone
authors.forename: M T
authors.initials: MT
authors.lastname: De Sanctis
authors.forename: L
authors.initials: L
authors.lastname: Incandela
authors.forename: R
authors.initials: R
authors.lastname: Minicucci
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015784:Betaxolol / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D002354:Carteolol / Q000627:therapeutic use*; D019842:Ciliary Arteries / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D009880:Ophthalmic Artery / Q000187:drug effects; D012161:Retinal Artery / Q000187:drug effects; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D013999:Timolol; D002354:Carteolol; D015784:Betaxolol